DK1381620T3 - Hypersulfaterede disaccharider og fremgangsmåder til anvendelse af samme til behandling af inflammationer - Google Patents
Hypersulfaterede disaccharider og fremgangsmåder til anvendelse af samme til behandling af inflammationerInfo
- Publication number
- DK1381620T3 DK1381620T3 DK02734003T DK02734003T DK1381620T3 DK 1381620 T3 DK1381620 T3 DK 1381620T3 DK 02734003 T DK02734003 T DK 02734003T DK 02734003 T DK02734003 T DK 02734003T DK 1381620 T3 DK1381620 T3 DK 1381620T3
- Authority
- DK
- Denmark
- Prior art keywords
- methods
- same
- treat inflammation
- hypersulfated disaccharides
- hypersulfated
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
- C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
- C08B37/006—Heteroglycans, i.e. polysaccharides having more than one sugar residue in the main chain in either alternating or less regular sequence; Gellans; Succinoglycans; Arabinogalactans; Tragacanth or gum tragacanth or traganth from Astragalus; Gum Karaya from Sterculia urens; Gum Ghatti from Anogeissus latifolia; Derivatives thereof
- C08B37/0063—Glycosaminoglycans or mucopolysaccharides, e.g. keratan sulfate; Derivatives thereof, e.g. fucoidan
- C08B37/0075—Heparin; Heparan sulfate; Derivatives thereof, e.g. heparosan; Purification or extraction methods thereof
- C08B37/0078—Degradation products
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7024—Esters of saccharides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/02—Nasal agents, e.g. decongestants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/08—Bronchodilators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/14—Antitussive agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/14—Decongestants or antiallergics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H11/00—Compounds containing saccharide radicals esterified by inorganic acids; Metal salts thereof
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
- C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
-
- C—CHEMISTRY; METALLURGY
- C40—COMBINATORIAL TECHNOLOGY
- C40B—COMBINATORIAL CHEMISTRY; LIBRARIES, e.g. CHEMICAL LIBRARIES
- C40B40/00—Libraries per se, e.g. arrays, mixtures
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Pulmonology (AREA)
- Genetics & Genomics (AREA)
- Biotechnology (AREA)
- Epidemiology (AREA)
- Materials Engineering (AREA)
- Polymers & Plastics (AREA)
- Rheumatology (AREA)
- Immunology (AREA)
- Urology & Nephrology (AREA)
- Otolaryngology (AREA)
- Dermatology (AREA)
- Physical Education & Sports Medicine (AREA)
- Pain & Pain Management (AREA)
- Ophthalmology & Optometry (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Saccharide Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US28479001P | 2001-04-16 | 2001-04-16 |
Publications (1)
Publication Number | Publication Date |
---|---|
DK1381620T3 true DK1381620T3 (da) | 2006-06-26 |
Family
ID=23091543
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK02734003T DK1381620T3 (da) | 2001-04-16 | 2002-04-16 | Hypersulfaterede disaccharider og fremgangsmåder til anvendelse af samme til behandling af inflammationer |
Country Status (13)
Country | Link |
---|---|
US (1) | US7056898B2 (da) |
EP (1) | EP1381620B1 (da) |
JP (1) | JP2005510453A (da) |
KR (1) | KR20040008157A (da) |
AR (1) | AR035827A1 (da) |
AT (1) | ATE321064T1 (da) |
CA (1) | CA2444761A1 (da) |
DE (1) | DE60210070T2 (da) |
DK (1) | DK1381620T3 (da) |
ES (1) | ES2258145T3 (da) |
NZ (1) | NZ529036A (da) |
PT (1) | PT1381620E (da) |
WO (1) | WO2002083700A2 (da) |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2005075490A2 (en) * | 2004-02-03 | 2005-08-18 | Ivax Corporation | Synthesis of polysulfated uronic acid glycosides |
EP1731131A1 (en) * | 2004-03-29 | 2006-12-13 | Kringle Pharma Inc. | Hgf production accelerator containing heparin-like oligosaccharide |
US7902158B2 (en) | 2004-08-05 | 2011-03-08 | Ivax Drug Research Ltd. | Polysulfated glycosides and salts thereof |
US20080249165A1 (en) * | 2004-08-05 | 2008-10-09 | Ivax Drug Research Institute Ltd. | Glycosides and Salts Thereof |
MX2012006265A (es) * | 2009-12-03 | 2012-07-25 | Opko Health Inc | Formulaciones disacaridas hipersulfatadas. |
EP2632259A4 (en) * | 2010-10-29 | 2015-04-29 | Opko Health Inc | HYPERSULATED DISACCHARIDES FOR THE TREATMENT OF ELASTASE-MEDIATED DISEASES |
JP5871500B2 (ja) * | 2011-06-20 | 2016-03-01 | 公益財団法人先端医療振興財団 | α−Klotho/FGF23複合体形成阻害化合物 |
TW201815394A (zh) | 2016-08-16 | 2018-05-01 | 美商歐科製藥有限公司 | 具有改良口服生物可利用性之純七硫酸化雙醣 |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IL85145A (en) | 1987-01-23 | 1994-08-26 | Univ Australian | Anti-metastatic pharmacological or veterinary preparations containing modified herpin with reduced anticoagulant activity |
US5827886A (en) * | 1997-05-07 | 1998-10-27 | Thione International, Inc. | Composition for relief of arthritis-induced symptoms |
-
2002
- 2002-04-16 WO PCT/US2002/012256 patent/WO2002083700A2/en active IP Right Grant
- 2002-04-16 ES ES02734003T patent/ES2258145T3/es not_active Expired - Lifetime
- 2002-04-16 NZ NZ529036A patent/NZ529036A/en not_active IP Right Cessation
- 2002-04-16 JP JP2002581455A patent/JP2005510453A/ja active Pending
- 2002-04-16 US US10/123,979 patent/US7056898B2/en not_active Expired - Fee Related
- 2002-04-16 AT AT02734003T patent/ATE321064T1/de active
- 2002-04-16 EP EP02734003A patent/EP1381620B1/en not_active Expired - Lifetime
- 2002-04-16 PT PT02734003T patent/PT1381620E/pt unknown
- 2002-04-16 KR KR10-2003-7013560A patent/KR20040008157A/ko not_active Application Discontinuation
- 2002-04-16 DE DE60210070T patent/DE60210070T2/de not_active Expired - Lifetime
- 2002-04-16 CA CA002444761A patent/CA2444761A1/en not_active Abandoned
- 2002-04-16 DK DK02734003T patent/DK1381620T3/da active
- 2002-04-16 AR ARP020101380A patent/AR035827A1/es not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
WO2002083700B1 (en) | 2003-09-18 |
US7056898B2 (en) | 2006-06-06 |
ES2258145T3 (es) | 2006-08-16 |
WO2002083700A2 (en) | 2002-10-24 |
JP2005510453A (ja) | 2005-04-21 |
NZ529036A (en) | 2005-11-25 |
PT1381620E (pt) | 2006-06-30 |
KR20040008157A (ko) | 2004-01-28 |
DE60210070D1 (de) | 2006-05-11 |
DE60210070T2 (de) | 2006-12-07 |
CA2444761A1 (en) | 2002-10-24 |
AR035827A1 (es) | 2004-07-14 |
EP1381620B1 (en) | 2006-03-22 |
US20030087875A1 (en) | 2003-05-08 |
ATE321064T1 (de) | 2006-04-15 |
WO2002083700A3 (en) | 2003-04-17 |
EP1381620A2 (en) | 2004-01-21 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK1485127T3 (da) | Anvendelse af midler til behandling af inflammation | |
DK1673104T3 (da) | Fremføring af terapeutiske forbindelser til hjernen og andre væv | |
DK1372767T3 (da) | Forbedring af og relaterende til en injektionsanordning | |
DK1390014T3 (da) | Sammensætning til anvendelse i en fremgangsmåde til behandling af hyperplasi | |
DK1667986T3 (da) | Acetonesolvat af dimethoxydocetaxel og fremgangsmåde til fremstilling heraf | |
IS6934A (is) | Nýjar spírótrísýklískar afleiður og notkun þeirrasem fosfódíesterasa-7-hindrar | |
DK1539224T3 (da) | Antimikrobielt præparat og fremgangsmåde til anvendelse | |
DK1651839T3 (da) | Afstands- og sprossestykker til isolering af glasenheder | |
DK1627639T3 (da) | Anvendelse af COX-2-inhibitorer til behandling af affektive lidelser | |
DE60139175D1 (de) | Entzerrer von Strahlungsleistungen | |
DK1278540T3 (da) | Anvendelse af IL-18-inhibitorer til behandling og/eller forebyggelsen af aterosklerose | |
DK1448205T3 (da) | Kombinationer til behandling af immunoinflammatoriske sygdomme | |
FI20011581A0 (fi) | Menetelmä ja laitteisto vesienergian hyödyntämiseksi | |
DK1432417T3 (da) | Substituerede imidazolforbindelser og deres anvendelse til behandling af cancer | |
DK1601744T3 (da) | Forgasningsapparat og fremgangsmåde | |
DK1248608T3 (da) | Diacerein til anvendelse i behandling af psoriasis | |
DK1355936T3 (da) | Polymerkonjugater af neublastin og fremgangsmåder til anvendelse af samme | |
DK1381382T3 (da) | Fremgangsmåder og præparater til behandling af öjensygdomme | |
DK1412486T3 (da) | Fremgangsmåde til virusformering | |
NO20033506D0 (no) | Parasittdrepende preparater og fremgangsmåter for anvendelse | |
DK1589973T3 (da) | Formulering og fremgangsmåder til behandling af thrombocytæmi | |
DK1313464T3 (da) | Fremgangsmåde til behandling af reaktiv athritis eller slimsæksbetændelse | |
DK1381620T3 (da) | Hypersulfaterede disaccharider og fremgangsmåder til anvendelse af samme til behandling af inflammationer | |
DK1667693T3 (da) | Præparater og fremgangsmåder til anvendelse af lamellare bodies til terapeutiske formål | |
NO20023737L (no) | Fremgangsmåte og preparater for behandling av en inflammatorisk lidelse |